PURPOSE: To study the molecular mechanisms of colorectal cancer liver metastasis. METHODS: Cecal wall implantation was performed in nude mice to subclone a highly liver metastatic human colorectal cancer clone (SW1116-M) from SW1116. In vivo and in vitro assays were adopted to confirm the proliferation and metastasis potential. The human tumor metastasis PCR microarrays were used to analyze the differential gene expressions. The results were confirmed further by real-time quantitative PCR. RESULTS: SW1116-M and SW1116-S5, two human colon cancer cell clones with different metastatic potential, were subcloned from SW1116. In SW1116-M, in vitro invasion, migration and in vivo metastatic potential were higher, and in vitro proliferation rate was lower than SW1116-S5. In tumor metastasis PCR microarray, 24 genes related to cell invading, adhesion, cellular growth and differentiation were found with a twofold difference between SW1116-S5 and SW1116-M. Sixteen of these, including E-cadherins, MTSS1, TRAIL and TRPM1, were up-regulated; eight genes including cathepsin L, EphB2, HGF, MET, MCAM and RORβ were down-regulated. CONCLUSIONS: We have established a highly liver metastatic clone. The subsequent metastasis PCR microarray analysis identified a procedure of cellular differentiation and mesenchymal to epithelial transition (MET) in liver metastasis. The colonization to from macrometastasis is not a switch from cell cycle arrest but a result of cell differentiation and MET.
PURPOSE: To study the molecular mechanisms of colorectal cancer liver metastasis. METHODS: Cecal wall implantation was performed in nude mice to subclone a highly liver metastatic humancolorectal cancer clone (SW1116-M) from SW1116. In vivo and in vitro assays were adopted to confirm the proliferation and metastasis potential. The humantumor metastasis PCR microarrays were used to analyze the differential gene expressions. The results were confirmed further by real-time quantitative PCR. RESULTS: SW1116-M and SW1116-S5, two humancolon cancer cell clones with different metastatic potential, were subcloned from SW1116. In SW1116-M, in vitro invasion, migration and in vivo metastatic potential were higher, and in vitro proliferation rate was lower than SW1116-S5. In tumor metastasis PCR microarray, 24 genes related to cell invading, adhesion, cellular growth and differentiation were found with a twofold difference between SW1116-S5 and SW1116-M. Sixteen of these, including E-cadherins, MTSS1, TRAIL and TRPM1, were up-regulated; eight genes including cathepsin L, EphB2, HGF, MET, MCAM and RORβ were down-regulated. CONCLUSIONS: We have established a highly liver metastatic clone. The subsequent metastasis PCR microarray analysis identified a procedure of cellular differentiation and mesenchymal to epithelial transition (MET) in liver metastasis. The colonization to from macrometastasis is not a switch from cell cycle arrest but a result of cell differentiation and MET.
Authors: Alessandro Ottaiano; Antonella di Palma; Maria Napolitano; Carmen Pisano; Sandro Pignata; Fabiana Tatangelo; Gerardo Botti; Angela Maria Acquaviva; Giuseppe Castello; Paolo Antonio Ascierto; Rosario Vincenzo Iaffaioli; Stefania Scala Journal: Cancer Immunol Immunother Date: 2004-12-11 Impact factor: 6.968
Authors: Maya Zigler; Gabriel J Villares; Andrey S Dobroff; Hua Wang; Li Huang; Russell R Braeuer; Takafumi Kamiya; Vladislava O Melnikova; Renduo Song; Ran Friedman; Rhoda M Alani; Menashe Bar-Eli Journal: Cancer Res Date: 2011-04-05 Impact factor: 12.701
Authors: Aram F Hezel; Vikram Deshpande; Stephanie M Zimmerman; Gianmarco Contino; Brinda Alagesan; Michael R O'Dell; Lee B Rivera; Jay Harper; Scott Lonning; Rolf A Brekken; Nabeel Bardeesy Journal: Cancer Res Date: 2012-07-11 Impact factor: 12.701
Authors: Matthew A Ginos; Grier P Page; Bryan S Michalowicz; Ketan J Patel; Sonja E Volker; Stefan E Pambuccian; Frank G Ondrey; George L Adams; Patrick M Gaffney Journal: Cancer Res Date: 2004-01-01 Impact factor: 12.701
Authors: A Anjomshoaa; S Nasri; B Humar; J L McCall; A Chatterjee; H-S Yoon; L McNoe; M A Black; A E Reeve Journal: Br J Cancer Date: 2009-08-04 Impact factor: 7.640
Authors: Gwladys Zabouo; Anne-Marie Imbert; Jocelyne Jacquemier; Pascal Finetti; Thomas Moreau; Benjamin Esterni; Daniel Birnbaum; François Bertucci; Christian Chabannon Journal: Breast Cancer Res Date: 2009-01-05 Impact factor: 6.466
Authors: Kelton A Schleyer; Ben Fetrow; Peter Zannes Fatland; Jun Liu; Maya Chaaban; Biwu Ma; Lina Cui Journal: ChemMedChem Date: 2021-01-15 Impact factor: 3.466